Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
04.03.2020 09:36:00

Halodoc Deploys More Available Doctors Amidst Coronavirus Outbreak

JAKARTA, Indonesia, 4 Maret 2020 /PRNewswire/ -- To increase community preparedness in anticipating the Coronavirus (COVID-19) outbreak, the integrated health platform Halodoc runs an official protocol for doctors within the Halodoc ecosystem. The said protocol covers standardized procedure of common signs identification, recommendations of treatment, and provision of referral hospital list from the Ministry of Health (Kemenkes). Halodoc also increased the number of available doctors to ensure all users can communicate with them regarding complaints related to Corona symptoms whenever and wherever they need.

The Ministry of Health has provided a 24-hour hotline following the identification of the first two positive COVID-19 cases in Indonesia. Meanwhile, World Health Organization (WHO) data showed that globally there were 88,948 COVID-19 cases as of 2 March 2020.

Halodoc VP of Marketing, Felicia Kawilarangsaid, "Since Corona began to be widely discussed at the beginning of the year, the number of searches for the term 'coronavirus' on the Halodoc platform has increased by six-fold. After the first two COVID-19 cases were confirmed by the government on March 2, the demand for preventive products like masks and supplements has increased significantly. We continue to optimize our technology-led ecosystem to facilitate user needs in anticipating the risks of Coronavirus with end-to-end approach. "

Furthermore, Halodoc has also activated preventive action by providing Coronavirus-related  education content in their platform to help users to learn more about the  symptoms that may include >38 degrees Celsius fever, sore throat, coughs, runny nose, nasal congestion, thick phlegm, shortness of breath, lung infections, diarrhea, nausea, and muscle aches.

When users have further concerns related to coronavirus, they can also communicate with more than 20,000 licensed and experienced doctors through the Halodoc platform. All general practitioners are capable of providing both initial and comparative diagnoses. If further observation is needed, doctors at Halodoc will refer those concerned to the nearest Ministry of Health referral hospital. Doctor appointments can also be booked through the Halodoc app by selecting the 'Make an Appointment in Hospital' or 'Hospital Appointment' menu and choose from a total of 132 hospitals recommended for Coronavirus.

At Halodoc app, the public can also buy face masks through pharmacy delivery service, at a lower price than the current market price. For instance, the Nexcare Daily mask is available at IDR 6,500, - per packet and Diapro (Skrineer) at the price of IDR 162,500 / box.

As a health platform that has been used by more than 11 million users across Indonesia, Halodoc will continue to keep abreast of developments in the Coronavirus outbreak in Indonesia and maximize its role in anticipating Corona risks through its technology expertise. "Users' health has always been our priority. With regard to the current development, we are doing our best to meet the needs of users in communicating with doctors, and to ensure that quality prevention products remain available on the Halodoc platform," Felicia concluded.

About Halodoc

Halodoc is an online-based integrated health application that provides complete and reliable health solutions to facilitate our access to healthcare. The Halodoc application is equipped with four main features, namely; "Chat with a doctor" that allows patients to chat, video call, or voice call with experienced and trusted doctors anytime anywhere from their cellular phone. Buy Medicines, a service that can help users buy supplements, vitamins, and medicines quickly, safely & comfortably because they are delivered directly to their address by online motorcycle taxis. Patients can also upload physical prescriptions to the application. Visiting a hospital allows patients to make an appointment with a doctor from the cellphone so that when they arrive at the hospital they do not need to trouble themselves with administration and can directly consult with doctors without having to wait in a long line, as well as Lab Services. Halodoc works closely with Prodia in making it easy for users to conduct health checks, both at home or in the office. In 2018, Halodoc received the "The Most Innovative Start-Up" award from Galen Growth Asia and was chosen directly by Forbes Indonesia as the "Start-Up Choice" for that year. In 2019, Halodoc was also chosen as "Startup Pilihan Tempo 2019" for People's Choice.

Media Contact:
Inmas Ayu (Nimas) - Artemis
+6281319155282
Halodoc Communications Consultant
inmas.ayu@artemishub.id

Photo - https://photos.prnasia.com/prnh/20200304/2738177-1

SOURCE Halodoc

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Insiderkäufe und Verkäufe – Wall Street Live mit Tim Schäfer

📈 Insider-Trades enthüllt: Welche Aktien die Top-Manager jetzt kaufen! 📊

Willst du wissen, welche Aktien Insider wie CEOs und Vorstände gerade aufkaufen? In unserem neuesten Video analysieren wir mit Tim Schäfer die spannendsten Insider-Käufe und -Verkäufe – von Unternehmen, die stark gefallen sind, bis hin zu Ausnahmen wie Rheinmetall und Commerzbank. Warum investieren Top-Manager gerade jetzt? Welche Aktien sind langfristig interessant? 🤔

In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Insiderkäufe und Verkäufe – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’587.25 19.18 UBSOUU
Short 13’851.11 13.73 JZUBSU
Short 14’386.90 8.75 U9VBSU
SMI-Kurs: 13’029.39 06.03.2025 17:30:35
Long 12’480.00 19.90
Long 12’193.57 13.45 BIUS1U
Long 11’677.86 8.81 BCLS7U
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten